Advancing Drug Discovery with the Precision and Power of AI

Rakovina Therapeutics is an AI-driven drug discovery company focused on DNA Damage Response (DDR) therapies for cancer. We combine advanced AI platforms with world-class research to discover and develop next-generation medicines that can transform lives.

THE RAKOVINA DIFFERENCE

Finding the signal that matters

AI-Powered Discovery

Multiple proprietary and partner AI platforms explore vast chemical space to identify high-potential drug candidates.

Focused Oncology Strategy

Targeting DNA Damage Response (DDR) pathways while developing therapies designed to cross the blood-brain barrier.

Wet-Lab Validation

Candidates validated in-house through established laboratory infrastructure at the University of British Columbia and the Vancouver Prostate Centre.

100% Candidate Ownership

Rakovina owns the rights to all drug candidates generated through its discovery programs.

OUR PIPELINE

A focused pipeline. Designed for impact.